Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analogues [Birth Defects Research, May 2022]

microRNAs signatures as potential biomarkers of structural cardiotoxicity in human-induced pluripotent stem-cell derived cardiomyocytes [Organ Toxicity and Mechanisms, April 2022]

Use of human induced pluripotent stem cell-derived cardiomyocytes to predict the cardiotoxicity potential of Next Generation Nicotine Products [Frontiers in Toxicology, February 2022]

The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes [Current Research in Toxicology, November 2020]

Profiling the ToxCast library with a pluripotent human (H9) stem cell line-based biomarker assay for developmental toxicity [Toxicological Sciences, April 2020]

A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential [Toxicological Sciences, April 2020]

A Human Induced Pluripotent Stem Cell-Based In Vitro Assay Predicts Developmental Toxicity Through a Retinoic Acid Receptor-Mediated Pathway for a Series of Related Retinoid Analogues [Reproductive Toxicology, 2017]

Stem Cell-Based Methods for Identifying Developmental Toxicity Potential [Predictive Toxicology, 2015]